PLSE Q3 2022 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q3 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$8M

Operating Income

-$18M

Net Income

-$18M

EPS (Diluted)

$-0.49

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$723,000

Balance Sheet

Total Assets

$88M

Total Liabilities

$81M

Stockholders' Equity

$6M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$574,000	-100.0%
Gross Profit	-$8M	-$153,000	-5390.2%
Operating Income	-$18M	-$14M	-26.3%
Net Income	-$18M	-$14M	-26.3%